- Investing Ideas
- /
- Global Healthcare Potentially Undervalued Companies
Global Healthcare Potentially Undervalued Companies
UPDATED May 16, 2022
Companies with a Value score of at least 3, ordered by Value score
967 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 7681LEOCLANLtd | JPÂĄ2,679.00 | -1.8% | -2.8% | JPÂĄ5.3b | n/a | PS15.1x | E24.8% | 1.9% | ||
| 1099Sinopharm Group | HK$18.16 | 0.7% | -30.4% | HK$56.7b | HK$23.45 | PS6.3x | E9.5% | 4.8% | ||
| 600535Tasly Pharmaceutical Group | CNÂĄ10.79 | 0.7% | -26.0% | CNÂĄ16.1b | CNÂĄ13.06 | PS10.9x | E16.6% | 3.1% | ||
| 1MDModern Dental Group | €0.31 | -7.7% | -33.2% | €2.5b | n/a | PS7x | E20.4% | 4.5% | ||
| ALEMGEuromedis Groupe | €6.13 | 5.1% | -65.2% | €18.3m | €19.00 | PS8.1x | E17.6% | 0% | ||
| OPA0Orpea | €6.45 | 5.7% | n/a | €2.2b | €13.14 | PS11.9x | E13.3% | 2.6% | ||
| ORPPOrpea | €32.34 | 0% | -70.0% | €2.2b | €65.89 | PS11.9x | E13.3% | 2.6% | ||
| ORPOrpea | €31.60 | 2.6% | -70.6% | €2.0b | €70.92 | PS10.8x | E13.3% | 2.8% | ||
| HUMHumana | kr49.85 | 4.3% | -28.1% | kr2.4b | kr79.00 | PS9.9x | E21.1% | 0% | ||
| 28China National Accord Medicines | CNÂĄ28.14 | -2.9% | -30.9% | CNÂĄ11.5b | CNÂĄ41.67 | PS9.6x | E15.8% | 2.1% | ||
| 688085Shanghai Sanyou Medical | CNÂĄ20.02 | -2.3% | -51.1% | CNÂĄ4.2b | n/a | PS21.7x | E25.1% | 0.9% | ||
| 1099Sinopharm Group | HK$18.16 | 0.7% | -30.4% | HK$56.7b | HK$23.45 | PS6.3x | E9.5% | 4.8% | ||
| AHXApiam Animal Health | AU$0.73 | -8.1% | -20.1% | AU$102.7m | AU$1.26 | PS23.9x | E39.9% | 3.3% | ||
| SHWG.YShandong Weigao Group Medical Polymer | US$4.02 | 0.5% | -54.5% | US$35.9b | US$6.27 | PS13.8x | E14.9% | 2.1% | ||
| UK2Shandong Weigao Group Medical Polymer | €0.91 | 1.1% | -51.5% | €35.9b | €1.42 | PS13.8x | E14.9% | 2.1% | ||
| SELECSelçuk Ecza Deposu Ticaret ve Sanayi | ₺12.92 | 3.7% | 37.2% | ₺8.0b | ₺16.31 | PS6.8x | E28.1% | 1.3% | ||
| OPAOrpea | €34.55 | 11.1% | -67.9% | €2.2b | €70.39 | PS11.9x | E13.3% | 2.6% | ||
| FSNU.YFresenius SE KGaA | US$8.70 | -3.7% | -37.0% | US$18.6b | US$11.56 | PS10.3x | E10.6% | 2.8% | ||
| SHTD.FSinopharm Group | US$2.35 | 9.8% | -30.2% | US$56.7b | US$3.03 | PS6.3x | E9.5% | 4.8% | ||
| OCAOceania Healthcare | AU$0.90 | -1.6% | -28.6% | AU$681.8m | AU$1.47 | PS6.6x | E-15.9% | 4.4% | ||
| SIGSigma Healthcare | AU$0.47 | -1.1% | -26.2% | AU$474.6m | n/a | PS-63.5x | E64.2% | 4.3% | ||
| 9103Medtecs International | NT$8.69 | -11.6% | -76.5% | NT$98.6m | NT$44.23 | PS4.1x | E20.5% | 4.6% | ||
| A041830InBodyLtd | â‚©27,050.00 | 0.9% | 2.3% | â‚©341.3b | â‚©40,000.00 | PS10.4x | E10.6% | 0.7% | ||
| 28China National Accord Medicines | CNÂĄ28.85 | -0.4% | -29.1% | CNÂĄ11.5b | CNÂĄ41.67 | PS9.8x | E15.8% | 2.1% |